Z-0295-2021 Class II Terminated
FDA device recall Z-0295-2021 was initiated by Becton Dickinson & Company on Sep 14, 2020 and is designated Class II. Reason for recall: Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit. The recall status is terminated (terminated Nov 9, 2021). Affected quantity: 72 units.
Recall details
- Product Type
- Devices
- Report Date
- Nov 4, 2020
- Initiation Date
- Sep 14, 2020
- Termination Date
- Nov 9, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 72 units
Product description
Bard 3F SL PowerMidline Full Kit CE-indicated for short term access to the peripheral venous system for selected intravenous therapies, blood sampling, and power injection of contrast media Ref: P6153208
Reason for recall
Kits do not contain the stylet/T-lock assembly indicated as a component on the label, may lead to a procedural delay and possibly discard of the kit.
Distribution pattern
Foreign: Italy, Spain, and UK
Code information
Lot Number: REEQ3598 Feb-2022 and REER0518 Mar-2022 UDI: 00801741141065
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0295-2021
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026